Midwest Institute for Clinical Research, Inc.

Indianapolis, Indiana 46260

0 studies enrolling now · 5 studies all time

What they study most

Hyperlipidemia, Hypertension, Mixed Dyslipidaemia, Severe Hypertriglyceridemia, Type 2 Diabetes Mellitus

Studies at this site

• A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia — Completed
• Study of AC-201 in Patients With Type 2 Diabetes Mellitus — Completed
• Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol — Completed
• PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM) — Completed
• A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients — Completed